Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genvoya in HIV-1/Hepatitis B Co-infected Adults
NCT02071082Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Feb 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of tenofovir alafenamide in human immunodeficiency virus type 1 infection (HIV-1), hepatitis B (HBV), sponsored by Gilead Sciences. Started Feb 2014; status: completed.
02
Drugs
tenofovir alafenamide
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02071082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02071082.